Characterization of naturally occurring and recombinant human N- acetyltransferase variants encoded by NAT1*

Molecular Pharmacology

Volumn 58, Issue 2, 2000, Pages 288-299

  De León, Jesús H ^a,b   Vatsis, Kostas P ^a   Weber, Wendell W ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBENZOIC ACID; AMINOSALICYLIC ACID; AROMATIC AMINE; BENZIDINE; MUTAGENIC AGENT; SULFADIMIDINE;

ACETYLATION; ADULT; ALLELE; AMINO ACID SEQUENCE; ARTICLE; CATALYSIS; DETOXIFICATION; EXON; FEMALE; GENE SEQUENCE; GENETIC POLYMORPHISM; HUMAN; HUMAN EXPERIMENT; IMMUNOREACTIVITY; MALE; MUTATION; PHARMACOGENETICS; POLYADENYLATION; PRIORITY JOURNAL; STEADY STATE; STRUCTURE ACTIVITY RELATION; THERMODYNAMICS;

EID: 0343627972     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.2.288     Document Type: Article

References (39)

1. Akada R (1994) Quick-check method to test the size of Escherichia coli plasmids. Biotechniques 17:58.
2. Andres HH, Klein AJ, Szabo SM and Weber WW (1985) New spectrophotometric and radiochemical assays for acetyl CoA:arylamine N-acetyltransferase applicable to a variety of arylamines. Anal Biochem 145:367-375.
3. Bell DA, Badawi AF, Lang NP, Ilett KF, Kadlubar FF and Hirvonen A (1995) Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: Association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res 55:5226-5229.
4. Berkhout B, Klaver B and Das AT (1995) A conserved hairpin structure predicted for the poly(A) signal of human and Simian immunodeficiency viruses. Virology 207: 276-281.
5. Bradford MM (1976) A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
6. Brown PH, Tiley LS and Cullen BR (1991) Effect of RNA secondary structure on polyadenylation site selection. Genes Dev 5:1277-1284.
7. 560A mutations. Pharmacogenetics 8:67-72.
8. Chen C and Okayama H (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752.
9. Cleland WW (1967) The statistical analysis of enzyme kinetic data. Adv Enzymol 29:1-32.
10. Cribb AE, Grant DM, Miller MA and Spielberg SP (1991) Expression of monomorphic arylamine N-acetyltransferase (NAT1) in human leukocytes. J Pharmacol Exp Ther 259:1241-1246.
11. de Leon JH (1996) Characterization of congenic mouse (NAT2*) and human (NAT1*) N-acetyltransferases. Ph.D. thesis, The University of Michigan.
12. Doll MA, Jiang W, Deitz AC, Rustan TD and Hein DW (1997) Identification of a novel allele at the human NAT1 acetyltransferase locus. Biochem Biophys Res Commun 233:584-591.
13. Dupret J-M, Goodfellow GH, Janezic SA and Grant DM (1994) Structure-function studies of human arylamine N-acetyltransferases NAT1 and NAT2: Functional analysis of recombinant NAT1/NAT2 chimeras expressed in Escherichia coli. J Biol Chem 269:26830-26835.
14. 68 in the catalytic mechanism of polymorphic human NAT2. J Biol Chem 267:7381-7385.
15. Grant DM, Blum M, Beer M and Meyer UA (1991) Monomorphic and polymorphic human arylamine N-acetyltransferases: A comparison of liver isozymes and expressed products of two cloned genes. Mol Pharmacol 39:184-191.
16. Grant DM, Hughes NC, Janezic SA, Goodfellow GH, Chen HJ, Gaedigk A, Yu VL and Grewal R (1997) Human acetyltransferase polymorphisms. Mutat Res 376:61-70.
17. Grant DM, Vohra P, Avis Y and Ima A (1992) Detection of a new polymorphism of human arylamine N-acetyltransferase NAT1 using p-aminosalicylic acid as an in vivo probe. J Basic Clin Physiol Pharmacol 3 (Suppl):244.
18. Hakes DJ and Dixon JE (1992) New vectors for high level expression of recombinant proteins in bacteria. Anal Biochem 202:293-298.
19. Hein DW, Ferguson RJ, Doll MA, Rustan TD and Gray K (1994) Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymes. Hum Mol Genet 3:729-734.
20. Hughes NC, Janezic SA, McQueen KL, Jewett MAS, Castranio T, Bell DA and Grant DM (1998) Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe. Pharmacogenetics 8:55-66.
21. Lin HJ, Han CY, Lin BK and Hardy S (1993) Slow acetylator mutations in the human polymorphic W-acetyltransferase gene in 786 Asians, Blacks, Hispanics, and Whites: Application to metabolic epidemiology. Am J Hum Genet 52:827-834.
22. Lin HJ, Probst-Hensch NM, Hughes NC, Sakamoto GT, Louie AD, Kau IH. Lin BK, Lee DB, Lin J, Frankl HD, Lee ER, Hardy S, Grant DM and Haile RW (1998) Variants of N-acetyltransferase NAT1 and a case-control study of colorectal adenomas. Pharmacogenetics 8:269-281.
23. McCarthy JEG and Kollmus H (1995) Cytoplasmic mRNA-protein interactions in eukaryotic gene expression. Trends Biochem Sci 20:191-197.
24. Nevins JR (1983) The pathway of eukaryotic mRNA formation. Annu Rev Biochem 52:441-466
25. Osterburg G and Sommer R (1981) Computer support of DNA sequence analysis. Comput Programs Biomed 13:101-109.
26. Sambrook J, Fritsch EF and Maniatis T (1989) Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
27. Segel IH (1975) Enzyme Kinetics. John Wiley & Sons, New York.
28. Sheets MD, Ogg SC and Wickens MP (1990) Point mutations in AAUAAA and the poly(A) addition site: effects on the accuracy and efficiency of cleavage and polyadenylation in vitro. Nucleic Acids Res 18:5799-5805.
29. Vatsis KP, Martell KJ and Weber WW (1991) Diverse point mutations in the human gene for polymorphic N-acetyltransferase. Proc Natl Acad Sci USA 88:6333-6337.
30. Vatsis KP and Weber WW (1993) Structural heterogeneity of Caucasian N-acetyltransferase at the NAT1 gene locus. Arch Biochem Biophys 301:71-76.
31. Vatsis KP and Weber WW (1994) Human N-acetyltransferases, in Handbook of Experimental Pharmacology: Conjugation-Deconjugation Reactions in Drug Metabolism and Toxicity (Kauffman FC ed) vol 122, pp 109-130, Springer-Verlag, Berlin.
32. Vatsis KP and Weber WW (1997) Acetyltransferases, in Comprehensive Toxicology: Biotransformation (Guengerich FP ed) vol 3, pp 385-399, Elsevier Science, Oxford.
33. Vatsis KP, Weber WW, Bell DA, Dupret J-M, Price Evans DA, Grant DM, Hein DW, Lin HJ, Meyer UA, Relling MV, Sim E, Suzuki T and Yamazoe Y (1995) Nomenclature for N-acetyltransferases. Pharmacogenetics 5:1-17.
34. Vatsis KP, Yao Y and Weber WW (1994) Allelic variation at the NAT1 locus of N-acetyltransferase among Orientals. Am J Hum Genet 55(suppl):A340.
35. Ward A, Summers MJ and Sim E (1995) Purification of recombinant human N-acetyltransferase type 1 (NAT1) expressed in E. coli and characterization of its potential role in folate metabolism. Biochem Pharmacol 49:1759-1767.
36. Weber WW (1987) The Acetylator Genes and Drug Response. Oxford University Press, New York.
37. Weber WW and Vatsis KP (1993) Individual variability in p-aminobenzoic acid N-acetylation by human N-acetyltransferase (NATI) of peripheral blood. Pharmacogenetics 3:209-212.
38. Zubiaga AM, Belasco JG and Greenberg ME (1995) The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol Cell Biol 15:2219-2230.
39. Zuker M and Stiegler P (1981) Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucleic Acids Res 9:133-148.